Serum keen on organic growth and denies Indian investments are acquisitive
This article was originally published in Scrip
Executive Summary
Serum Institute is keen to stick to organic growth and its investments in the Indian companies, Orchid Chemicals & Pharmaceuticals and Panacea Biotec, have no acquisitive overtones.